SCHEMBL16433237

SCHEMBL16433237

COc1ccc(CNc2ncnc3c2ccn3[C@@H]2O[C@H](CN=[N+]=[N-])[C@H]3OC(C)(C)O[C@H]32)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 10/20 0.41
▸ CYP3A4 P08684 10/20 0.41
▸ CLK4 Q9HAZ1 10/20 0.41
▸ CYP2C19 P33261 9/20 0.41
▸ ALDH1A1 P00352 9/20 0.41
▸ HSD17B10 Q99714 8/20 0.41
▸ CYP2D6 P10635 8/20 0.41
▸ USP2 O75604 7/20 0.41
▸ TSHR P16473 6/20 0.41
▸ LMNA P02545 6/20 0.41
▸ MAPK1 P28482 5/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ CYP2C9 P11712 5/20 0.41
▸ ALOX15 P16050 2/20 0.39
▸ ADORA3 P0DMS8 3/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PRMT5 O14744 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16433238 1.00 CYP1A2 (0.41) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9105747 0.88 CYP1A2 (0.44) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9105754 0.88 CYP1A2 (0.44) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9109338 0.88 ADORA3 (0.46) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9288345 0.87 CYP1A2 (0.44) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9288354 0.87 CYP1A2 (0.44) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9288723 0.85 CYP1A2 (0.42) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9282034 0.85 CYP1A2 (0.42) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL15381405 0.85 CYP1A2 (0.41) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1
SCHEMBL9287140 0.81 CYP1A2 (0.39) CYP1A2CYP3A4CLK4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3027774-B1 METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPONSIVE TO DOT1L INHIBITION MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2020-07-15 — — EP disclosed
EP-3027774-A1 METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPONSIVE TO DOT1L INHIBITION Memorial Sloan Kettering Cancer Center (US) 2016-06-08 — — EP disclosed
WO-2015017863-A1 METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPONSIVE TO DOT1L INHIBITION MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2015-02-05 — — WO disclosed
Send feedback